Skip to content

Hyperbaric oxygen therapy for benign anastomotic esophageal strictures: a pilot study

Hyperbaric oxygen therapy for benign anastomotic esophageal strictures: a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26778
Enrollment
10
Registered
2013-12-05
Start date
2013-11-27
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign recurrent or refractory anastomotic strictures as a result of esophagectomy. Benign anastomic stricture esophagectomy Benigne anastomose strictuur oesofagectomie

Interventions

Hyperbaric Oxygen Therapy in 30 sessions of 110 minutes at 2.5 atmospheres. -The patient breathes 100% oxygen by a closed breathing apparatus (face mask or hood) inside a space (room) where the press

Sponsors

University Medical Center Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Benign esophageal anastomotic stricture; defined as a stenosis at the esophagogastric anastomosis causing clinically significant dysphagia. -Clinically significant dysphagia; defined as grade 2 or worse on the Ogilvie scale -First presentation of dysphagia due to the stricture within 6 months after surgery -Recurrent or refractory stricture: -> 5 previous dilation sessions for this indication within the last 12 months -Last dilation < 1 week before the start of hyperbaric oxygen therapy -Informed Consent

Exclusion criteria

Exclusion criteria: -Known or strongly suspected esophageal motility disorder -Known or strongly suspected malignant stricture -Non-anastomotic esophageal stricture -Contra indication for hyperbaric oxygen therapy: oUntreated pneumothorax oRestrictive treated pneumothorax (without thoraxdrain) oSevere respiratory diseases (COPD or pulmonary emphysema) oActive infection of the upper airways oRecent surgery of the middle ear oRecent thoracic surgery oUncontrolled high fever oEpilepsy oTreatment with pulmonary toxic medication (bleomycine, doxorubicin, adriamycin, amiodaron, furadantine) oPrevious treatment with bleomycine with pulmonary toxic reaction oKnown pregnancy or premenopausal woman that are not surgically sterile or taking oral contraceptives

Design outcomes

Primary

MeasureTime frame
To assess the effect of hyperbaric oxygen therapy on the mucosal capillary hemoglobin oxygen saturation levels in the esophagus and the gastric tube

Secondary

MeasureTime frame
- To assess the effect of hyperbaric oxygen therapy on: - dysphagia symptoms - quality of life (QLQ-C30 + OES 18)

Contacts

Public ContactW.F.W. Kappelle

P.O. box 85500 University Medical Center Utrecht Department of Gastroenterology & Hepatology Room F02.618

w.f.w.kappelle@umcutrecht.nl+31 (0)88 5750724

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)